Allurion Technologies Inc.

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

ALUR.WS

ALUR+

ALUR

ALURW

The NYSE has announced the commencement of delisting proceedings against Allurion Technologies, Inc. (ALUR) due to the company's failure to meet the continued listing standard of maintaining an average global market capitalization of at least $15 million over a 30-day period. Trading in ALUR's common stock and warrants will be suspended immediately. The company has the right to appeal this decision to a Committee of the Board of Directors of the Exchange before the NYSE applies to the SEC for delisting.

MorningStar

ALLURION TECHNOLOGIES INC C/WTS 01/08/2030 (TO PUR COM)

Allurion Tech

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

FFAI

CHIQ

LVWR

YMAT

In Monday's intraday session, J-Star Holding (NASDAQ:YMAT) saw a significant gain of 64.2%, reaching $0.61, with a market cap of $6.4 million. Allurion Technologies (NYSE:ALUR) rose by 48.62% to $1.62, while Faraday Future (NASDAQ:FFAI) increased by 20.14% to $0.54. On the downside, United Homes Group (NASDAQ:UHG) fell 51.5% to $1.15, and LiveWire Group (NYSE:LVWR) dropped 18.16% to $1.81. Other notable losers included Algorhythm Holdings (NASDAQ:RIME) and Netclass Technology (NASDAQ:NTCL), which fell by 16.83% and 16.19%, respectively.

benzinga_article

Faraday Future Intelligent Electric

Global X China Consumer

Livewire

J-Star

SPDR S&P Retail ETF

United Homes

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

Allurion Technologies shares are trading higher after the company announced FDA approval for its gastric balloon system application.

SPDR S&P Health Equip

iShares US Medical Devices

DTCR

ALAR

IDGT

XDAT

CLOU

SRVR

Alarum Technologies Ltd. (NASDAQ: ALAR) experienced a 17.9% decrease in short interest in January, with 114,239 shares sold short as of January 30th. The short-interest ratio is currently 2.0 days, representing 1.6% of the stock. Institutional investors have increased their stakes, with Renaissance Technologies boosting its holdings by 34.6%. Analysts have mixed ratings, with a consensus rating of "Hold" and a target price of $22.00. Alarum's shares opened at $7.47, with a market cap of $54.08 million and a recent EPS of $0.19, surpassing estimates.

Allurion Technologies Inc.(ALUR.WS.US)

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

Allurion Technologies shares are trading higher after the company announced FDA approval for its gastric balloon system application.

Alarum Technologies Ltd. Sponsored ADR (NASDAQ:ALAR) Short Interest Update